Access All Areas
The Commercial Eyes Market Access and Pricing team consists of highly experienced consultants with a practical and thorough understanding of the challenges to market access in Australia and New Zealand for pharmaceuticals, nutritional products, blood products, vaccines, devices, diagnostics and medical services.
Our team carefully assess your objective and leverage their in-depth knowledge of local and international healthcare markets, payer systems and policy, to provide strategic, clinical, statistical, economic and pricing advice that will give your product the best chance of success. With a highly collaborative approach, we balance technical accuracy with the seamless delivery of a clear and meaningful value story in the context of our dynamic and complex reimbursement system. Our insights into market dynamics and the needs of payers, our access to key data sources, and our established relationships with influential stakeholders will be at your disposal.
The Market Access team can provide an end-to-end service including:
Reimbursement feasibility and pricing assessments
Reimbursement strategy development, including the facilitation of cross-functional workshops
Submissions for Health Technology Assessment (PBAC, MSAC, PLAC, NBA, PHARMAC, co-dependent submissions)
Economic and budget impact modelling
Meta-analysis and indirect treatment comparisons
Government relations strategy development
Analysis of PBAC outcomes and PBS pricing
Funding proposals to PHI and the federal budget
Please contact Tenille Manuele (Director, Market Access & Pricing) to discover how Commercial Eyes can assist you to envisage, achieve and defend the optimum market access outcomes for your product or service.